Phase II trial of extended-dosing temozolomide in patients with melanoma Meeting Abstract


Authors: Rietschel, P.; Ejadi, S.; Wolchok, J.; Krown, S.; Gerst, S.; Jungbluth, A.; Busam, K.; Panageas, K.; Smith, K.; Chapman, P.
Abstract Title: Phase II trial of extended-dosing temozolomide in patients with melanoma
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 479s
Language: English
ACCESSION: WOS:000455043702273
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.8531
Notes: Meeting Abstract: 8531 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Samuel Ejadi
    4 Ejadi
  2. Jedd D Wolchok
    905 Wolchok
  3. Scott R Gerst
    48 Gerst
  4. Paul Chapman
    326 Chapman
  5. Katherine S Panageas
    519 Panageas
  6. Achim Jungbluth
    458 Jungbluth
  7. Klaus J Busam
    690 Busam
  8. Susan Krown
    156 Krown
  9. Katherine M Smith
    33 Smith